SOURCE: Elsevier Business Intelligence

Elsevier Business Intelligence

February 16, 2010 14:16 ET

Medtech Business Experts Will Identify 'Hot Deals' at Elsevier's 'IN3 West' Investor Conference, Las Vegas, March 4-5, 2010

Largest Annual Strategic Partnership and Investment Meeting Follows 'Medical Device Investor Day' at Same Venue on March 3rd

LAS VEGAS, NV--(Marketwire - February 16, 2010) - Elsevier Business Intelligence, the medtech industry's leading strategic partner and investment conference organizer, announced today that it will host 'IN3 West' on March 4-5, 2010, at The Venetian Resort-Hotel-Casino, Las Vegas. This annual event follows 'Medical Device Investor Day,' also being held at The Venetian, on March 3rd, 2010.

One of several panel discussions at the conference will be: "Medical Device Investing, Financing and Exit Strategies: What are the Hot Deals Now and in the Future?" Moderated by David Cassak, Managing Director, Elsevier Business Intelligence, additional experts will include Nimesh S. Shah, Principal, Domain Associates; and Jim Scopa, Managing Director, MPM Capital.

"Medical technology start-ups continue to encounter fierce competition for a fixed volume of accessible capital resources. The good news is that IN3 events extend a golden opportunity for young companies to engage and persuade potential investors among numerous top-shelf device companies and savvy healthcare investment firms from around the world," said David Cassak.

Large Device Companies & Investors Scheduled to Present: RCT BioVentures - Prism Ventures - Pappas Ventures - Delphi Ventures - Apposite Capital - Synergy Life Science Partners - New Leaf Venture Partners - Medtronic - Aisling Capital - Essex Woodlands Health Ventures - Safeguard Scientifics - Stryker Corp. - Covidien Domain Assoc. - Baird Venture Partners - Versant Ventures - And more!

The prelude to IN3 West will be Medical Device Investor Day on March 3rd, also at The Venetian Resort-Hotel, Las Vegas. This special event will bring together early-, mid-, and late-stage medtech innovators along with the biggest medical device dealmakers in financing, partnering, and M&A. Medical Device Investor Day is critically important to medtech innovators interested in what the investment leaders in the space are looking for in terms of technologies, therapeutic areas, products, and geographic markets. They will specifically disclose partnering opportunities and how to maximize visibility in front of big-company investors, as well as discuss what the landscape for M&A is expected to look like in this new year.

For more information about IN3 West and Medical Device Investor Day, please contact: Kristy Grimes at 1-480-985-9512 or Kayleen Kell at 1-888-290-2225 (USA only), or email IN3@Elsevier.com.

Additional IN3 events in 2010: April 29-30: IN3 Europe, Paris (www.IN3Europe.com): "Bridging European and U.S. Medical Device Innovators, Investors and Companies" (Marriott Rive Gauche Hotel). June 9-11: IN3 East, Boston (www.IN3East.com): "Investment In Innovation (In3) East + Investor Day: The Largest East Coast Strategic Partnership and Investment Meeting for Medical Technology Executives" (The Westin Copley Place). For more information, please contact: Kristy Grimes at 1-480-985-9512 or Kayleen Kell at 1-888-290-2225 (USA only), or email IN3@Elsevier.com.

About Elsevier Business Intelligence

Elsevier Business Intelligence, an Elsevier company, is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, databases and reports, Elsevier Business Intelligence places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. Elsevier Business Intelligence (http://www.elsevierbi.com) has offices in the U.S. in Bridgewater, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine, Calif.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as Science Direct (www.sciencedirect.com), MDConsult (www.mdconsult.com), Nursing Consult (www.nursingconsult.com), Scopus (www.info.scopus.com), bibliographic databases, and online reference works.

Elsevier (www.elsevier.com) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (www.reedelsevier.com), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Contact Information